In this study, we evaluated the effects of LPS treatment and DOK3 overexpression (OE) on U251MG glioblastoma cells, focusing on inflammatory cytokine expression, oxidative stress markers, and tumor-related processes. The gene discussed is DOK3; the disease is glioblastoma.